Insider Transactions in Q1 2022 at Guardant Health, Inc. (GH)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 10
2022
|
Stanley J Meresman Director |
SELL
Open market or private sale
|
Direct |
4,934
-54.86%
|
$286,172
$58.74 P/Share
|
|
Mar 10
2022
|
Stanley J Meresman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,934
+35.43%
|
$24,670
$5.94 P/Share
|
|
Feb 10
2022
|
Stanley J Meresman Director |
SELL
Open market or private sale
|
Direct |
4,934
-54.86%
|
$360,182
$73.8 P/Share
|
|
Feb 10
2022
|
Stanley J Meresman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,934
+35.43%
|
$24,670
$5.94 P/Share
|
|
Jan 15
2022
|
Michael Brian Bell Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,246
-37.67%
|
$95,942
$77.58 P/Share
|
|
Jan 15
2022
|
Michael Brian Bell Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,308
+50.0%
|
-
|
|
Jan 10
2022
|
Stanley J Meresman Director |
SELL
Open market or private sale
|
Direct |
4,934
-54.86%
|
$424,324
$86.08 P/Share
|
|
Jan 10
2022
|
Stanley J Meresman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,934
+35.43%
|
$24,670
$5.94 P/Share
|